Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone add-on therapy for recent-onset psychotic disorder
NL-OMON46871Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia, schizoaffective disorder, schizophreniform disorder and 1 more comparing Prednisolone plus standard antipsychotic treatment with Placebo plus standard antipsychotic treatment (2 arms). Primary endpoint: Change in PANSS total score from baseline. Started Apr 2015; status: active, not recruiting.
02
Drugs
prednisolone
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorderSchizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON46871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46871.